These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25640490)

  • 1. Evaluation of blood parameters for the monitoring of erythrodermic cutaneous T-cell lymphoma.
    Vandersee S; Humme D; Terhorst D; Almohamad A; Möbs M; Beyer M
    J Dtsch Dermatol Ges; 2015 Jan; 13(1):30-6. PubMed ID: 25640490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome.
    Introcaso CE; Hess SD; Kamoun M; Ubriani R; Gelfand JM; Rook AH
    J Am Acad Dermatol; 2005 Sep; 53(3):428-34. PubMed ID: 16112348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4
    Vonderheid EC; Hou JS
    Leuk Lymphoma; 2018 Feb; 59(2):330-339. PubMed ID: 28595473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
    Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.
    Quaglino P; Knobler R; Fierro MT; Savoia P; Marra E; Fava P; Bernengo MG
    Int J Dermatol; 2013 Nov; 52(11):1308-18. PubMed ID: 23786842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
    Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Steitz J; Roszkiewicz J; Bieber T; Tüting T
    Clin Exp Dermatol; 2005 Nov; 30(6):702-6. PubMed ID: 16197392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas.
    Tancrède-Bohin E; Ionescu MA; de La Salmonière P; Dupuy A; Rivet J; Rybojad M; Dubertret L; Bachelez H; Lebbé C; Morel P
    Arch Dermatol; 2004 Sep; 140(9):1057-61. PubMed ID: 15381544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis.
    Horna P; Deaver DM; Qin D; Moscinski LC; Sotomayor EM; Glass LF; Sokol L
    J Clin Pathol; 2014 May; 67(5):431-6. PubMed ID: 24319102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the diagnosis of erythrodermic cutaneous T-cell lymphoma.
    Vonderheid EC
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():27-42. PubMed ID: 16412210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of clinical and molecular responses to bexarotene treatment in cutaneous T-cell lymphoma.
    Ballanger F; Nguyen JM; Khammari A; Dréno B
    Dermatology; 2010; 220(4):370-5. PubMed ID: 20484880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.
    Introcaso CE; Kim EJ; Gardner J; Junkins-Hopkins JM; Vittorio CC; Rook AH
    Arch Dermatol; 2008 Aug; 144(8):1027-9. PubMed ID: 18711076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood sCD3⁻ CD4⁺ T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma.
    Singh A; Schabath R; Ratei R; Stroux A; Klemke CD; Nebe T; Flörcken A; van Lessen A; Anagnostopoulos I; Dörken B; Ludwig WD; Pezzutto A; Westermann J
    Hematol Oncol; 2014 Mar; 32(1):16-21. PubMed ID: 23798351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment.
    Goldman BD; Oh SK; Davis BE; Kadin ME; Poiesz BJ; Koh HK
    Arch Dermatol; 1993 Sep; 129(9):1166-70. PubMed ID: 8363402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
    Lan TT; Brown NA; Hristov AC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma.
    Heald P; Yan SL; Edelson R
    Arch Dermatol; 1994 Feb; 130(2):198-203. PubMed ID: 8304758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.